Innovation Pharmaceuticals Inc (IPIX): I would be extremely cautious with this...

Reply Private New

Replies (8) Next 10 Prev Next

Send PM Follow Ignore

Re: None

Monday, 06/22/2020 5:23:08 PM

Monday, June 22, 2020 5:23:08 PM

I would be extremely cautious with this one.

The company has a history with touting big news that is in fact fluff.

In this case, the company claims that a U.S. Regional Biocontainment Laboratory is testing Brilacidin. It seems to be correct, but the scientist who performs the testing is doing so only because of a $35k grant from the company:

https://www.google.dk/amp/s/www.news-medical.net/amp/news/20200605/George-Mason-researcher-examining-the-use-of-Brilacidin-for-treatment-of-coronavirus-infections.aspx

https://www.niaid.nih.gov/research/george-mason-regional-biocontainment-lab

https://stockdaymedia.com/innovation-pharmaceuticals-brilacidin-inhibits-sars-cov-2-covid-19-by-97-percent-in-a-human-lung-cell-line/

Keep Last Read

Replies (8) Next 10 Prev Next

Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 01:30:25 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 09:25:58 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:05:44 PM
Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 01:00:19 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 08:15:25 PM
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/28/2023 01:00:08 PM

InvestorsHub NewsWire

Only $200 per official company press release!